Company, Human health, Animal health
Revatis is pleased to announce that our abstract has been selected for an oral presentation at the 3rd World Congress on Targeting Extracellular Vesicles, to be held on 12-13 November in Porto, Portugal. "Cytokine priming enhances anti-neutrophil activity of an equine extracellular vesicle-enriched muscle-derived mesenchymal stem cell secretome".
This work examines how cytokine priming influences the functional anti-inflammatory activity of an EV-enriched secretome produced from equine muscle-derived mesenchymal stem cells. We look forward to presenting these results and discussing their scientific and translational implications with the extracellular vesicle community
Congress information: https://lnkd.in/eVQ5tikT
#ExtracellularVesicles #secretome #MesenchymalStemcells #RegenerativeMedicine #Revatis